Edwards Lifesciences Corp SEC Filing

Edwards Lifesciences Corporation submitted a Rule 144 notice reporting proposed transactions in Common stock.

Accepted by SEC EDGAR 05/11/2026 - 04:10 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Edwards Lifesciences Corporation submitted a Rule 144 notice reporting proposed transactions in Common stock. The form lists 47,280.00 (reported figure) and a separate numeric entry 575,800,000. It also shows restricted stock lapse events of 19 shares on 05/07/2025 and 574 shares on 05/07/2026.

Insights

Securities Compliance Counsel

Rule 144 notice lists proposed resale quantities and restricted stock lapses.

The filing lists numeric entries including 47,280.00 and 575,800,000, plus restricted stock lapses of 19 shares on 05/07/2025 and 574 shares on 05/07/2026. These entries appear as disclosures of planned or reportable actions under resale rules.

Timing and cash‑flow treatment are not specified in the excerpt; subsequent regulatory filings or broker confirmations would clarify execution and settlement details.

Key Figures

Reported numeric entry: 47,280.00 Reported numeric entry: 575,800,000 Restricted stock lapse: 19 shares +1 more

4 metrics

Reported numeric entry 47,280.00 Listed on the Rule 144 form

Reported numeric entry 575,800,000 Listed on the Rule 144 form

Restricted stock lapse 19 shares Lapse date <date>05/07/2025</date>

Restricted stock lapse 574 shares Lapse date <date>05/07/2026</date>

Key Terms

Restricted Stock Lapse, Rule 144, Charles Schwab & Co., Inc.

3 terms

Restricted Stock Lapse financial

"Restricted Stock Lapse | EDWARDS LIFESCIENCES CORPORATION | 19 | 05/07/2025"

Rule 144 regulatory

"CONTENT METADATA: "form_type": "144""

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Charles Schwab & Co., Inc. other

"Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001991414
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Markowitz Wayne
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	593	47280.00	575800000	05/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2025	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			19	05/07/2025	Equity Compensation
Common	05/07/2026	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			574	05/07/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	WAYNE MARKOWITZ
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)